首页> 外文OA文献 >Hyaluronan Oligosaccharides Inhibit Tumorigenicity of Osteosarcoma Cell Lines MG-63 and LM-8 in Vitro and in Vivo via Perturbation of Hyaluronan-Rich Pericellular Matrix of the Cells
【2h】

Hyaluronan Oligosaccharides Inhibit Tumorigenicity of Osteosarcoma Cell Lines MG-63 and LM-8 in Vitro and in Vivo via Perturbation of Hyaluronan-Rich Pericellular Matrix of the Cells

机译:透明质酸寡糖通过扰动透明质酸丰富的细胞周质基质抑制体外和体内骨肉瘤细胞MG-63和LM-8的致瘤性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Numerous studies have demonstrated a correlation between hyaluronan expression and the malignant properties of various kinds of cancer , and inhibition of hyaluronan production causes decreased tumor growth. Hyaluronan oligosaccharides have been shown to inhibit several tumor cell types via disrup- tion of receptor-hyaluronan interaction. However, few studies have addressed hyaluronan with respect to osteosarcoma. In this study, we examined the ef- fects of exogenously added hyaluronan oligosaccha- rides on tumorigenicity of murine osteosarcoma cells, LM-8, and human osteoblastic osteosarcoma cells, MG-63. Moreover, the critical size of oligomers needed to inhibit malignant properties was defined. Fluorescent hyaluronan oligosaccharides accumu- lated both on the surface of cells and in the cyto- plasm, and this retention was blocked by pretreat- ment with an anti-CD44 monoclonal antibody. Hyaluronan octasaccharides significantly inhibited cell viability and induced apoptosis as defined by cell proliferation and terminal deoxynucleotidyl trans- ferase dUTP nick-end labeling assays, respectively. Octasaccharides also abrogated functional cell-associ- ated matrices and significantly reduced the retention of endogenous hyaluronan. Further, octasaccharide treatment affected an inhibition of cell motility as well as cell invasiveness. Pretreatment of the cells withanti-CD44antibodyreducedtheantitumoreffect of the octasaccharides. In vivo , intratumoral injection of hyaluronan octasaccharides reduced the hyaluronan accumulation in local tumors, resulting in significant suppression of the formation of distant lung metastasis. Together these data suggest that hyaluronan oligosac- charides have potent antitumor effects functioning in part by the abrogation of hyaluronan-rich cell-associated matrices. Originally published American Journal of Pathology, Vol. 171, No. 1, July 2007
机译:大量研究表明,透明质酸的表达与各种癌症的恶性特性之间存在相关性,并且抑制透明质酸的产生会导致肿瘤生长降低。透明质酸寡糖已通过抑制受体与透明质酸的相互作用而抑制了几种肿瘤细胞类型。但是,关于骨肉瘤的透明质酸研究很少。在这项研究中,我们研究了外源添加的透明质酸寡糖对鼠骨肉瘤细胞LM-8和人成骨性骨肉瘤细胞MG-63的致瘤性。此外,定义了抑制恶性特性所需的低聚物的临界尺寸。荧光透明质酸寡糖在细胞表面和细胞质中均积累,并且这种抗性被抗CD44单克隆抗体预处理所阻断。透明质酸八糖显着抑制细胞活力并诱导凋亡,这分别由细胞增殖和末端脱氧核苷酸转移酶dUTP缺口末端标记测定确定。八糖还消除了功能性细胞相关基质,并显着降低了内源性透明质酸的保留。此外,八糖治疗影响细胞运动性以及细胞侵袭性的抑制。用抗CD44抗体预处理细胞可降低八糖的抗肿瘤作用。在体内,透明质酸八糖瘤内注射减少了透明质酸在局部肿瘤中的积累,从而显着抑制了远处肺转移的形成。这些数据一起表明,透明质酸寡糖具有有效的抗肿瘤作用,部分原因是由于富含透明质酸的细胞相关基质的废除。最初出版的《美国病理学杂志》第1卷。 171,第1号,2007年7月

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号